Daveen Chopra is CVP, TMTT of Edwards Lifesciences Corp. Currently has a direct ownership of 33,496 shares of EW, which is worth approximately $2.47 Million. The most recent transaction as insider was on May 11, 2023, when has been sold 6,475 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.5K
21.44% 3M change
9.52% 12M change
Total Value Held $2.47 Million

Daveen Chopra Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 11 2023
BUY
Grant, award, or other acquisition
-
6,475 Added 20.28%
25,450 Common Stock
May 08 2023
SELL
Payment of exercise price or tax liability
$85,811 $88.74 p/Share
967 Reduced 4.85%
18,975 Common Stock
May 07 2023
SELL
Payment of exercise price or tax liability
$161,684 $88.74 p/Share
1,822 Reduced 8.37%
19,942 Common Stock
May 07 2023
BUY
Exercise of conversion of derivative security
-
3,413 Added 13.56%
21,764 Common Stock
May 04 2023
SELL
Payment of exercise price or tax liability
$24,579 $88.1 p/Share
279 Reduced 1.5%
18,351 Common Stock
May 03 2023
SELL
Payment of exercise price or tax liability
$24,674 $87.81 p/Share
281 Reduced 1.49%
18,630 Common Stock
Mar 15 2023
SELL
Open market or private sale
$343,579 $77.47 p/Share
4,435 Reduced 19.0%
18,911 Common Stock
Mar 15 2023
BUY
Exercise of conversion of derivative security
$200,816 $45.28 p/Share
4,435 Added 15.96%
23,346 Common Stock
Feb 15 2023
SELL
Open market or private sale
$304,040 $76.01 p/Share
4,000 Reduced 17.46%
18,911 Common Stock
Feb 15 2023
BUY
Exercise of conversion of derivative security
$181,120 $45.28 p/Share
4,000 Added 14.86%
22,911 Common Stock
Jan 17 2023
SELL
Open market or private sale
$312,000 $78.0 p/Share
4,000 Reduced 17.46%
18,911 Common Stock
Jan 17 2023
BUY
Exercise of conversion of derivative security
$181,120 $45.28 p/Share
4,000 Added 14.86%
22,911 Common Stock
Dec 15 2022
SELL
Open market or private sale
$299,200 $74.8 p/Share
4,000 Reduced 17.46%
18,911 Common Stock
Dec 15 2022
BUY
Exercise of conversion of derivative security
$181,120 $45.28 p/Share
4,000 Added 14.86%
22,911 Common Stock
Nov 15 2022
SELL
Open market or private sale
$296,720 $74.18 p/Share
4,000 Reduced 17.46%
18,911 Common Stock
Nov 15 2022
BUY
Exercise of conversion of derivative security
$181,120 $45.28 p/Share
4,000 Added 14.86%
22,911 Common Stock
Oct 14 2022
SELL
Open market or private sale
$339,080 $84.77 p/Share
4,000 Reduced 17.46%
18,911 Common Stock
Oct 14 2022
BUY
Exercise of conversion of derivative security
$181,120 $45.28 p/Share
4,000 Added 14.86%
22,911 Common Stock
Aug 02 2022
SELL
Open market or private sale
$102,490 $102.49 p/Share
1,000 Reduced 5.02%
18,911 Common Stock
May 26 2022
SELL
Open market or private sale
$98,310 $98.31 p/Share
1,000 Reduced 4.78%
19,911 Common Stock
May 17 2022
SELL
Payment of exercise price or tax liability
$157,709 $95.93 p/Share
1,644 Reduced 7.29%
20,911 Common Stock
May 08 2022
SELL
Payment of exercise price or tax liability
$449,224 $100.52 p/Share
4,469 Reduced 16.54%
22,555 Common Stock
May 08 2022
BUY
Exercise of conversion of derivative security
-
8,531 Added 23.99%
27,024 Common Stock
May 07 2022
SELL
Payment of exercise price or tax liability
$30,659 $100.52 p/Share
305 Reduced 1.62%
18,493 Common Stock
May 04 2022
SELL
Payment of exercise price or tax liability
$29,554 $105.93 p/Share
279 Reduced 1.46%
18,798 Common Stock
DC

Daveen Chopra

CVP, TMTT
Irvine, CA

Track Institutional and Insider Activities on EW

Follow Edwards Lifesciences Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW